CCL21 and neoplasm: The receptor CCR7 and its ligand CCL21 have been implicated in the lymphatic spread of tumor [63] when CCR7 is expressed by melanoma cells [64] and when CCL21 is expressed by lymphatic endothelial cells [65,66].